切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2023, Vol. 12 ›› Issue (02) : 163 -166. doi: 10.3877/cma.j.issn.2095-3224.2023.02.012

综述

结直肠癌肝转移发生机制的研究进展
金玺1, 孙康1,(), 郭建1, 孔梅1,()   
  1. 1. 212001 镇江,江苏大学附属医院胃肠外科
  • 收稿日期:2022-08-10 出版日期:2023-04-25
  • 通信作者: 孙康, 孔梅
  • 基金资助:
    镇江市社会发展项目(SH2019089)

Research progress in the mechanism of colorectal cancer liver metastases

Xi Jin1, Kang Sun1,(), Jian Guo1, Mei Kong1,()   

  1. 1. Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
  • Received:2022-08-10 Published:2023-04-25
  • Corresponding author: Kang Sun, Mei Kong
引用本文:

金玺, 孙康, 郭建, 孔梅. 结直肠癌肝转移发生机制的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2023, 12(02): 163-166.

Xi Jin, Kang Sun, Jian Guo, Mei Kong. Research progress in the mechanism of colorectal cancer liver metastases[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(02): 163-166.

结直肠癌是消化道系统最常见的恶性肿瘤之一,随着生活水平的提高呈逐年上升趋势,而结直肠癌肝转移(CRLM)是导致患者死亡的最主要原因之一。目前对于结直肠癌的发生机制尚未完全阐明,因此对CRLM发生机制的深入研究,将有助于对结直肠癌患者的检查、诊断和治疗。本文通过总结国内外相关文献,介绍CRLM的潜在发生机制。

Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive system which is increasing year by year with the improvement of living standard. Colorectal liver metastases(CRLM) is the leading cause of death of patients. The molecular mechanism of colorectal cancer has not been fully elucidated, so the in-depth study of the molecular mechanism of CRLM will be helpful for the examination, diagnosis and treatment of patients with colorectal cancer. This paper summarized the domestic and foreign literature to introduce the current research status of CRLM.

[1]
Feng QY, Wei Y, Chen JW, et al. Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases[J]. World J Gastroenterol, 2014, 20(15): 4263-4275.
[2]
Tang B, Liang W, Liao Y, et al. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway[J]. Oncol Rep, 2019, 41(1): 43-56.
[3]
Lindgren M, Rask G, Jonsson J, et al. Type IV collagen in human colorectal liver metastases—cellular origin and a circulating biomarker[J]. Cancers, 2022, 14(14): 3396.
[4]
张敏, 冯怡锟, 张岩, 等. 结直肠腺癌组织中MMP2、ADAM17及E-cadherin的表达及临床意义[J]. 癌症进展, 2020, 18(4): 414-417.
[5]
魏双琴, 李迎春, 张成, 等. MMP-7、MMP-9基因多态性与结直肠癌发病的关系研究[J]. 中国现代医学杂志, 2018, 28(2): 42-46.
[6]
Barabás L, Hritz I, István G, et al. The behavior of MMP-2, MMP-7, MMP-9, and their inhibitors TIMP-1 and TIMP-2 in adenoma-colorectal cancer sequence[J]. Dig Dis, 2021, 39(3): 217-224.
[7]
Böckelman C, Beilmann-Lehtonen I, Kaprio T, et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer[J]. BMC Cancer, 2018, 18(1): 679.
[8]
郑香伟, 陈克河, 康继厚. Ataxin-3和MMP-11在伴肝转移结直肠癌组织中的表达及临床意义[J]. 临床肿瘤学杂志, 2019, 24(5): 401-405.
[9]
Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Signal transduction and targeted therapy, 2022, 7(1): 3.
[10]
李炜玉, 黄圆圆, 江志敏, 等. Wnt通路激活的结直肠癌细胞抑制肿瘤浸润性树突细胞成熟的机制研究[J]. 岭南现代临床外科, 2019, 19(2): 162-168.
[11]
Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer[J]. Biomedicine & Pharmacotherapy, 2019, 110: 473-481.
[12]
Sun K, He SB, Yao YZ, et al. Tre2 (USP6NL) promotes colorectal cancer cell proliferation via Wnt/β-catenin pathway[J]. Cancer Cell International, 2019, 19: 1-12.
[13]
Tang Q, Chen J, Di Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer[J]. Journal of Experimental & Clinical Cancer Research, 2020, 39(1): 232.
[14]
Fei R, Wei QS, Xiang D. CD133: A cancer stem cells marker, is used in colorectal cancers[J]. World Journal of Gastroenterology, 2013, 19(17): 2603-2611.
[15]
Grosse-Gehling P, Fargeas CA, Dittfeld C, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges[J]. The Journal of Pathology, 2013, 229(3): 355-378.
[16]
Nguyen PH, Giraud J, Chambonnier L, et al. Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinomabiomarkers of tumorigenic and chemoresistant gastric CSCs[J]. Clinical Cancer Research, 2017, 23(6): 1586-1597.
[17]
Wang W, Wan P, Lai F, et al. Double-stranded RNA targeting calmodulin reveals a potential target for pest management of Nilaparvata lugens[J]. Pest management science, 2018, 74(7): 1711-1719.
[18]
Terraneo N, Jacob F, Peitzsch C, et al. L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population[J]. Cancers, 2020, 12(1): 217.
[19]
Mansoori B, Mohammadi A, Naghizadeh S, et al. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer[J]. Journal of Cellular Physiology, 2020, 235(2): 920-931.
[20]
Zhang Y, Ma LN, Xie Y. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1[J]. European review for medical and pharmacological sciences, 2020, 24(4): 1778-1785.
[21]
陈贝贝, 吕慧芳, 别良玉, 等. MicroRNA-375表达对大肠癌细胞生物学特性的影响[J]. 现代肿瘤医学, 2017, 25(22): 3558-3563.
[22]
杨秀春, 王盼, 余涛, 等. miRNA-107在胃癌、结直肠癌及其癌前病变中的表达水平及临床意义[J]. 中国中西医结合消化杂志, 2020, 28(1): 52-57.
[23]
张学明, 裴永彬, 张峰, 等. 血浆微RNA-224在结直肠癌中的诊断价值[J]. 肿瘤, 2014, 34(7): 623-628.
[24]
Bhattacharya R, Ye XC, Wang R, et al. Intracrine VEGF signaling mediates the activity of prosurvival pathways in human colorectal cancer cells[J]. Cancer research, 2016, 76(10): 3014-3024.
[25]
Bhattacharya R, Fan F, Wang R, et al. Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion[J]. British journal of cancer, 2017, 117(6): 848-855.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[4] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[5] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[6] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[7] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[8] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[9] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[10] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[11] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[12] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[13] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[14] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[15] 陈秋怡, 林熙, 刘珍银. 淋巴管畸形分子机制的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 374-379.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?